全文获取类型
收费全文 | 10973篇 |
免费 | 1082篇 |
国内免费 | 287篇 |
专业分类
耳鼻咽喉 | 111篇 |
儿科学 | 283篇 |
妇产科学 | 267篇 |
基础医学 | 720篇 |
口腔科学 | 136篇 |
临床医学 | 1342篇 |
内科学 | 1689篇 |
皮肤病学 | 148篇 |
神经病学 | 364篇 |
特种医学 | 476篇 |
外科学 | 1342篇 |
综合类 | 1964篇 |
预防医学 | 1720篇 |
眼科学 | 144篇 |
药学 | 770篇 |
18篇 | |
中国医学 | 108篇 |
肿瘤学 | 740篇 |
出版年
2024年 | 14篇 |
2023年 | 176篇 |
2022年 | 393篇 |
2021年 | 597篇 |
2020年 | 511篇 |
2019年 | 458篇 |
2018年 | 493篇 |
2017年 | 454篇 |
2016年 | 390篇 |
2015年 | 428篇 |
2014年 | 790篇 |
2013年 | 774篇 |
2012年 | 630篇 |
2011年 | 722篇 |
2010年 | 551篇 |
2009年 | 589篇 |
2008年 | 614篇 |
2007年 | 486篇 |
2006年 | 458篇 |
2005年 | 380篇 |
2004年 | 332篇 |
2003年 | 257篇 |
2002年 | 208篇 |
2001年 | 197篇 |
2000年 | 161篇 |
1999年 | 135篇 |
1998年 | 123篇 |
1997年 | 108篇 |
1996年 | 98篇 |
1995年 | 97篇 |
1994年 | 95篇 |
1993年 | 46篇 |
1992年 | 60篇 |
1991年 | 69篇 |
1990年 | 60篇 |
1989年 | 61篇 |
1988年 | 61篇 |
1987年 | 46篇 |
1986年 | 42篇 |
1985年 | 27篇 |
1984年 | 26篇 |
1983年 | 15篇 |
1982年 | 17篇 |
1981年 | 14篇 |
1980年 | 12篇 |
1979年 | 8篇 |
1978年 | 7篇 |
1974年 | 5篇 |
1971年 | 19篇 |
1970年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
《Revue d'épidémiologie et de santé publique》2020,68(1):33-36
BackgroundControversies around organized breast cancer screening emphasize the need for information for women. In France, the institute of cancer (INCa) is in charge of conveying this information. Cancer Rose's website (CR) provides complementary information considering INCa's incomplete. The objective of this study was to identify if these informations meet criteria for decision aid.MethodsInformation documents were selected and analyzed using International Patient Decision Aid Standards (IPDAS). Each item was noted A (absent), P (present) or I (present but incomplete).ResultsInformation booklet and press kit for INCa and studies section for CR were the document meeting most criteria. The document meeting fewer criteria were the INCa's video and information leaflet for CR. Videos are more accessible tools for people with lower levels of health literacy. INCa's video did not present the risks of screening and CR's emphasized the risks.ConclusionThese documents have not been evaluated for intelligibility, clarity and readability. Addressing these criteria limits social inequities and improves health literacy. 相似文献
2.
3.
《Drug discovery today》2022,27(6):1733-1742
Compounds that exhibit assay interference or undesirable mechanisms of bioactivity are routinely encountered in assays at various stages of drug discovery. We observed that assays for the investigation of thiol-reactive and redox-active compounds have not been collected in a comprehensive review. Here, we review these assays and subject them to experimental optimization to improve their reliability. We demonstrate the usefulness of our assay cascade by assaying a library of bioactive compounds, chemical probes, and a set of approved drugs. These high-throughput assays should complement the array of wet-lab and in silico assays during the initial stages of hit discovery campaigns to pursue only hit compounds with tractable mechanisms of action. 相似文献
4.
5.
6.
《Vaccine》2021,39(34):4759-4765
Dengue vaccination would enhance the control of dengue, one of the most frequent vector-borne viral diseases globally. CYD-TDV is the first dengue vaccine to be licensed, but global uptake has been hampered due to its use being limited to seropositive persons aged 9 years and above, and the need for a 3-dose schedule. The Partnership for Dengue Control (PDC) organized a meeting with key opinion leaders and stakeholders to deliberate on implementation strategies for the use of CYD-TDV. New data have emerged that support the shortening of the primary schedule from a 3 to 2 dose schedule, extending the age range below 9 to 6 years of age, and expanding the indication from endemic populations to also include travelers to endemic areas. Cost-effectiveness may improve with the modified 2-dose regimen and with multiple testing. Strategies to implement a dengue vaccination program have been developed, in particular school-based strategies. A range of delivery scenarios can then be considered, using various settings for each step of the intervention. However, several challenges remain, including communication about limiting the use of this vaccine to seropositive individuals only. Affordability will vary from country to country, as will government commitment and community acceptance. Well-tailored communication strategies that target key stakeholders are expected to make up a significant part of any future dengue vaccination program. 相似文献
7.
Mehdi Karimi Shahri Hamid R. Niazkar Fariba Rad 《International journal of laboratory hematology》2021,43(2):160-168
In December 2019, a new type of coronavirus was detected for the first time in Wuhan, Hubei Province, China. According to the reported data, the emerging coronavirus has spread worldwide, infecting more than fifty-seven million individuals, leading to more than one million deaths. The current study aimed to review and discuss the hematological findings of COVID-19. Laboratory changes and hematologic abnormalities have been reported repeatedly in COVID-19 patients. WBC count and peripheral blood lymphocytes are normal or slightly reduced while these indicators may change with the progression of the disease. In addition, several studies demonstrated that decreased hemoglobin levels in COVID-19 patients were associated with the severity of the disease. Moreover, thrombocytopenia, which is reported in 5%-40% of patients, is known to be associated with poor prognosis of the disease. COVID-19 can present with various hematologic manifestations. In this regard, accurate evaluation of laboratory indicators at the beginning and during COVID-19 can help physicians to adjust appropriate treatment and provide special and prompt care for those in need. 相似文献
8.
9.
10.
Lesley A. Inker Morgan E. Grams Andrew S. Levey Josef Coresh Massimo Cirillo John F. Collins Ron T. Gansevoort Orlando M. Gutierrez Takayuki Hamano Gunnar H. Heine Shizukiyo Ishikawa Sun Ha Jee Florian Kronenberg Martin J. Landray Katsuyuki Miura Girish N. Nadkarni Carmen A. Peralta Dietrich Rothenbacher Mark Woodward 《American journal of kidney diseases》2019,73(2):206-217